Recent news highlights Taylor Devices’ quarterly earnings increases year-over-year driven by lower costs and strong aerospace demand, with profit climbing in Q3 2026 and prior quarters showing mixed results including profit declines and surges linked to defense demand.

• Taylor Devices reported Q3 earnings increase year-over-year driven by lower costs [N1].
• Q3 profit climbed as reported in late March 2026 [N2].
• Q2 earnings soared year-over-year due to aerospace demand [N3].
• Q1 profit fell as reported in October 2025 [N5].
• Q4 earnings surged year-over-year on defense demand in 2025 [N6].
• The company announced an increase in Q4 profit in August 2025 [N7].

The company’s increasing revenue and net income in recent periods, driven by aerospace and defense demand, demonstrate operational strength. Cost management efforts have improved operating income and reduced selling expenses. Strong liquidity and a sizable backlog provide financial flexibility and potential revenue conversion over the next two years. The company’s focus on aerospace/defense, a sector with specialized requirements, supports differentiated product demand and customer relationships.

Revenue and backlog have shown fluctuations, with a notable decrease in backlog from the prior year, which may impact future revenue recognition. Sales concentration in aerospace/defense exposes the company to sector-specific risks and potential demand variability. Inventory includes items sensitive to technological obsolescence, which could lead to write-downs. The company’s results are subject to project timing and competitive pressures, and fluctuations in international sales add geographic risk.

Taylor Devices’ moat is supported by its specialized product offerings serving aerospace/defense and structural markets, which require technical expertise and long-term project execution capabilities. The company’s backlog and customer relationships in these sectors provide some revenue visibility. Its strong liquidity position and investment in research and development support ongoing operations and product development. However, the company faces typical industry risks such as project timing variability, technological obsolescence in inventory, and competitive pressures in its markets.

• Backlog and Revenue Timing Risk: The company’s backlog decreased from $33.3 million to $20.8 million year-over-year, and revenue recognition depends on project completion timing, which can cause fluctuations in financial results.
• Sector Concentration Risk: A large portion of sales is concentrated in the aerospace/defense sector, which may be subject to changes in government spending and industry demand cycles.
• Inventory Obsolescence Risk: Maintenance and other inventory items have long product life cycles but are sensitive to technological obsolescence, potentially leading to write-downs.
• Competitive and Market Risks: The company faces competition and pricing pressures, and changes in customer capital budgets or project demand can materially affect results.

• Taylor Devices, Inc. is a company that reports financial results through SEC filings including a 10-K filed on 2026-08-18 and a 10-Q filed on 2026-03-31 [S1][S2].
• The company reported fiscal year 2026 revenue of approximately $41.65 million and net income of about $8.56 million as of 2026-05-31 [S1].
• Basic earnings per share for fiscal year 2026 were $2.70 and diluted EPS was $2.62 [S1].
• Liquidity as of 2026-05-31 includes cash and equivalents of $904,823 and short-term investments of about $40.57 million, with a current ratio of 12.76 and a cash ratio of 8.48, indicating strong liquidity [S1].
• The company’s business includes sales to three main customer groups: industrial, structural, and aerospace/defense, with aerospace/defense representing the largest share (66% for nine months ended February 28, 2026) [S1].
• Sales are primarily domestic (87% U.S. for nine months ended February 28, 2026) with some international sales to Asia and other regions [S1].
• Revenue and net income have shown increases year-over-year in recent periods, with net revenue increasing 6% and net income increasing 17% for the nine months ended February 28, 2026 compared to the prior year [S1].
• The company’s backlog decreased from $33.3 million at February 28, 2025 to $20.8 million at February 28, 2026, with expectations to recognize most backlog revenue during fiscal years 2026 and 2027 [S1].
• Research and development expenses were about 1.1% of net revenue for the nine months ended February 28, 2026, showing a slight increase from the prior year [S1].
• Selling, general and administrative expenses decreased by 6% for the nine months ended February 28, 2026 compared to the prior year, primarily due to lower employee incentive compensation accruals [S1].
• Operating income increased to $6.79 million for the nine months ended February 28, 2026 from $5.87 million the prior year, driven by increased revenue and lower SG&A expenses [S1].
• Other income increased by 22% to $1.23 million for the nine months ended February 28, 2026, mainly from short-term investment interest income [S1].
• Inventory levels decreased by 10% year-over-year as of February 28, 2026, with about 90% of inventory classified as work-in-process [S1].
• Accounts receivable decreased by 13% year-over-year as of February 28, 2026, while costs and estimated earnings in excess of billings increased by 6% [S1].
• The company’s quarterly results for the three months ended February 28, 2026 showed a 6% increase in net revenue and a 25% increase in net income compared to the prior year quarter [S1].
• Sales mix shifted in the quarter ended February 28, 2026 with aerospace/defense sales increasing to 77% of net revenue, while industrial and structural sales declined [S1].
• Recent news reports highlight quarterly earnings increases year-over-year driven by lower costs and aerospace demand, with Q3 2026 earnings increasing and profit climbing [N1][N2][N3].
• Earlier news coverage notes fluctuations in quarterly profits, including Q1 profit declines and Q4 earnings surges driven by defense demand [N5][N6][N7].